| A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) (NCT05429970) | Memorial Sloan Kettering Cancer Center | 2022-06-17 |
| Ask Questions (ASQ):Implementation of a Communication Intervention (NCT05025748) | Barbara Ann Karmanos Cancer Institute | 2021-08-25 |
| Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer (NCT04811703) | Hospices Civils de Lyon | 2021-07-30 |
| Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy (NCT04204811) | Memorial Sloan Kettering Cancer Center | 2019-12-16 |
| 18F-DCFPyL PET/CT in High-grade Epithelial Ovarian Cancer (PET HOC) (NCT03811899) | University Health Network, Toronto | 2019-04-01 |
| Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer (NCT03297489) | Roswell Park Cancer Institute | 2017-11-06 |
| Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer (NCT03154190) | Stanford University | 2017-08-08 |
| IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery (NCT03029611) | University of Washington | 2017-04-03 |
| Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors (NCT03198286) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-08-01 |
| Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis (NCT02441140) | Dana-Farber Cancer Institute | 2015-05-01 |
| Ovarian Cancer Patient-Centered Decision Aid (NCT02259699) | University of California, Irvine | 2014-12-01 |
| HOT: HIPEC in Ovarian Cancer as Initial Treatment (NCT02124421) | Mercy Medical Center | 2014-04-01 |
| Salvage Ovarian FANG™ Vaccine + Carboplatinum (NCT01867086) | Gradalis, Inc. | 2013-06-01 |
| Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer (NCT01650376) | Swedish Medical Center | 2012-08-01 |
| Interactive Educational Website for Women With Ovarian Cancer & Caregivers (NCT01626014) | University of Minnesota | 2012-08-01 |
| Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer (NCT01196429) | National Cancer Institute (NCI) | 2010-08-01 |
| Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer (NCT00814086) | Gynecologic Oncology Group | 2009-02-01 |
| Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy (NCT00551265) | Gynecologic Oncology Group | 2007-10-01 |
| Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors (NCT00301756) | National Cancer Institute (NCI) | 2006-09-01 |
| Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer (NCT00352300) | Gynecologic Oncology Group | 2006-06-01 |
| Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer (NCT00066456) | Gynecologic Oncology Group | 2003-09-01 |
| Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer (NCT00060359) | Gynecologic Oncology Group | 2003-04-01 |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer (NCT00011986) | Gynecologic Oncology Group | 2001-01-01 |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer (NCT00004221) | Gynecologic Oncology Group | 1999-11-01 |
| Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer (NCT00003532) | Burzynski Research Institute | 1996-03-05 |